Skip Navigation

European Heart Journal 2002 23(20):1559-1560; doi:10.1053/euhj.2002.3271
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilcken, D.E.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcken, D.E.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Homocysteine, smoking and vascular disease

D.E.L. Wilcken

Department of Cardiovascular Medicine, University of New South Wales, Prince of Wales Hospital, Sydney, Australia

References

  1. Carson N, Cusworth D, Dent C. Homocystinuria: a new inborn error of metabolism associated with mental deficiency. Archives of diseases in childhood. 1963;38:425–436[ISI][Medline]
  2. Mudd S, Finkelstein J, Irreverre F. Homocystinuria: An enzymatic defect. Science. 1964;143:1443–1445[Abstract/Free Full Text]
  3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128[ISI][Medline]
  4. Mudd SH, Skovby F, Levy HL. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1–31[ISI][Medline]
  5. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis. 1997;20:295–300[CrossRef][ISI][Medline]
  6. Yap S, Boers GH, Wilcken B. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21:2080–2085[Abstract/Free Full Text]
  7. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976;57:1079–1082[ISI][Medline]
  8. Wang XL, Tam C, McCredie RM. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974–1981[Abstract/Free Full Text]
  9. Refsum H, Ueland PM, Nygard O. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62[CrossRef][ISI][Medline]
  10. Seshadri S, Beiser A, Selhub J. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–483[Abstract/Free Full Text]
  11. Nygard O, Vollset SE, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526–1533[Abstract]
  12. O’Callaghan P, Meleady R, Fitzgerald T. Smoking and plasma homocysteine. Eur Heart J. 2002;23:1580–1586[Abstract/Free Full Text]
  13. Doshi SN, McDowell IF, Moat SJ. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol. 2001;21:1196–1202[Abstract/Free Full Text]
  14. Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:6–13[Abstract/Free Full Text]
  15. Usui M, Matsuoka H, Miyazaki H. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Lond). 1999;96:235–239[Medline]
  16. Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett. 2000;486:159–162[CrossRef][ISI][Medline]
  17. Morrow JD, Frei B, Longmire AW. Increase in circulating products of lipid peroxidation (F2–isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198–1203[Abstract/Free Full Text]
  18. Clarke R, Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 1998;5:249–255[Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilcken, D.E.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcken, D.E.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?